Clin2
NCT07293910Likely a fitRecruiting

Comparing treatments for H. pylori infection

HELICOBACTER PYLORI INFECTIONSHelicobacter InfectionHelicobacter Pylori Gastrointestinal Tract InfectionHelicobacter Pylori Infected Patients

Treatments studied

Part of Infections clinical trials.

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
66 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 79 years old.
  • You have tested positive for H. pylori using a stool test, breath test, or endoscopy.
  • You have not received any treatment for H. pylori before.
  • You have not taken antibiotics, acid-reducing medicines, or certain other drugs in the past month.
  • You do not have active liver disease, kidney problems, or a history of stomach bleeding or surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07275827Not yet recruiting· Phase 3
Testing 3 treatments for H. pylori infection

This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.

Shibīn al Kawm
NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07720037Not yet recruiting· Phase 4
Comparing short vs standard H. pylori treatment

This study compares two shorter antibiotic treatments for H. pylori, a stomach bacteria that can cause ulcers. Both treatments use the medicines vonoprazan and amoxicillin for 10 or 14 days, and the goal is to see if the shorter course works just as well.

NCT07750938Not yet recruiting· Phase 4
Optimized treatment for H. pylori infection with stronger acid control

This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.

NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.

Hear when a new Helicobacter Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.